Hotline:
+ 49 (0) 2204 2918806

Market studies for category Allergy/Immunology

Items 1 to 10 of 159 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 16
  1. Net price*
    Year
  2. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Peanut Allergy - Pipeline Review, H1 2014

    Global Markets Direct
    55 pages
    Global Markets Direct’s, ‘Peanut Allergy - Pipeline Review, H1 2014’, provides an overview of the Peanut Allergy’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peanut Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mech
    Englisch | Zukunftsanalyse | SKU: 404005
  3. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Masitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

    GlobalData
    84 pages
    Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) and the prevalence is expected to grow to just over 8.5 million individua
    Englisch | Zukunftsanalyse | SKU: 987678546
  4. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Chronic Inflammation - Pipeline Review, H1 2014

    Global Markets Direct
    61 pages
    Global Markets Direct’s, ‘Chronic Inflammation - Pipeline Review, H1 2014’, provides an overview of the Chronic Inflammation’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Inflammation, complete with comparative analysis at various stages, therapeutics assessment by
    Englisch | Zukunftsanalyse | SKU: 394202
  5. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Sarcoidosis - Pipeline Review, H1 2015

    Global Markets Direct
    59 pages
    Global Markets Direct’s, ‘Sarcoidosis - Pipeline Review, H1 2015’, provides an overview of the Sarcoidosis’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Sarcoidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of
    Englisch | Zukunftsanalyse | SKU: 987678414
  6. $3,995.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    EpiCast Report: Myasthenia Gravis - Epidemiology Forecast to 2024

    GlobalData
    37 pages
    Myasthenia gravis is an autoimmune disease that affects the nerves and muscles and is characterized by muscle weakness and fatigue, especially weakness of the muscles controlling eye and eyelid movement, facial expression, chewing and talking. In some cases the muscles controlling breathing are also affected, which can lead to respiratory
    Englisch | Zukunftsanalyse | SKU: 987688703
  7. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis

    GlobalData
    40 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis. The RA market is currently very dynamic, with the November 6, 2012 FDA approval of Pfizer’s Xeljanz (tofacitinib) and novel oral therapies awaiting approval such as: Eli Lilly’s anti-BAFF, tabalu
    Englisch | Report | SKU: 329562
  8. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Becker Muscular Dystrophy - Pipeline Review, H2 2014

    Global Markets Direct
    40 pages
    Global Markets Direct’s, ‘Becker Muscular Dystrophy - Pipeline Review, H2 2014’, provides an overview of the Becker Muscular Dystrophy’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Becker Muscular Dystrophy, complete with comparative analysis at various stages, therapeutic
    Englisch | Zukunftsanalyse | SKU: 987671717
  9. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Pollen Allergy - Pipeline Review, H1 2015

    Global Markets Direct
    103 pages
    Global Markets Direct’s, ‘Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Pollen Allergy’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mech
    Englisch | Zukunftsanalyse | SKU: 987680144
  10. $9,995.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Crohn’s Disease - Global Drug Forecast and Market Analysis to 2022

    GlobalData
    305 pages
    The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as - - Takeda’s alpha4beta7 inhibitor, Entyvio (vedolizumab)- Johnson & Johnson’s (J&J’s) interleukin (IL)-12/23 inhibitor, Stelara (ustekinumab)These compounds will challenge the current biologics in an attempt to dislod
    Englisch | Marktstudie | SKU: 402027
  11. $4,995.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis to 2023

    GlobalData
    223 pages
    Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) and the prevalence is expected to grow to just over 8.5 million individual
    Englisch | Zukunftsanalyse | SKU: 987678504

Items 1 to 10 of 159 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 16